ONESOURCE - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 2.0
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones could be established between 1,570 ₹ (a level of previous support) and 1,600 ₹ (the DMA 50). A stop-loss order should be placed around 1,530 ₹ to protect capital against a potential downside reversal. The ongoing momentum, coupled with the high RSI, could see the stock target 1,700 ₹ in the short to medium term if the recent earnings and communications continue to drive optimism. However, continued scrutiny of financials and the persistent overvaluation risk necessitates cautious monitoring.
✅ Positive
The price is currently trading above the 200-day moving average (DMA 200) of 1,620 ₹ and exhibiting a noticeable increase in volume compared to its one-week average, suggesting potential upward momentum. Furthermore, the RSI reading of 54.9 indicates that the stock isn't overbought, leaving room for continued price appreciation.
⚠️ Limitation
The extremely high P/E ratio of 345 relative to the industry PE of 34.8 presents a significant valuation concern and suggests potential overvaluation based on current earnings. A substantial correction could occur if growth expectations aren’t met. The recent downgrade from MarketsMojo reinforces this risk.
📉 Company Negative News
OneSource Specialty Pharma has been downgraded to "Sell" by MarketsMojo due to weak financials and technical signals, indicating concerns about the company's performance.
📈 Company Positive News
The company announced a record profit growth of 106% Qtr-on-Qtr, and added RPT details to its AGM notice for September 23rd – which suggests upcoming investor communication efforts may be adding support to stock prices.
🏭 Industry
The pharmaceutical sector, particularly specialty pharma, is currently experiencing moderate volatility driven by broader market trends and ongoing regulatory changes impacting drug pricing and development. The industry PE of 34.8 indicates a generally reasonable valuation, but OneSource’s high P/E relative to the industry suggests it's operating under different assumptions or faces unique risks.